Using nanotechnology to empower people worldwide with rapid, affordable, and portable diagnostic information about their own health.

Nanobiosym Diagnostics has built and is now commercializing its FDA-authorized platform for Personalized Precision Medicine called Gene-RADAR. Harnessing more than 20 years of award-winning science and technology at the convergence of physics, nanotechnology, ICT, and biomedicine, Nanobiosym Dx is working to decentralize, democratize, mobilize, and personalize the next generation of healthcare delivery. The company aims to empower 8 billion consumers with real-time personalized mobile diagnostics and exponentially increase access to accurate diagnostics for anyone, anywhere and at any time. This includes the 4 billion people people globally who currently lack access to information about their health. Nanobiosym is part research institute and part incubator, advancing the frontiers of nanobiophysics and harnessing these innovations with novel business models and public-private partnerships to address our planet’s greatest unmet needs.


Health Infrastructure Economic Inequality

Cambridge, Massachusetts, United States


Anita Goel

Anita Goel (Founder, Chairman, CEO at Nanobiosym) has been an Unreasonable Fellow since March 2019 and most recently participated in The Unreasonable Impact COVID-19 Response Global Summit, created with Barclays.

The Unreasonable Impact COVID-19 Response Global Summit, created with Barclays

Connect with Nanobiosym

Follow Nanobiosym on social media below or check for open jobs on their careers page.

  • Featured VentureGeneral Fusion

  • Featured VentureClara Foods